Found: 3
Select item for more details and to access through your institution.
AZD3409 inhibits the growth of breast cancer cells with intrinsic resistance to the EGFR tyrosine kinase inhibitor gefitinib.
- Published in:
- Breast Cancer Research & Treatment, 2007, v. 102, n. 3, p. 275, doi. 10.1007/s10549-006-9340-7
- By:
- Publication type:
- Article
The role of the EGFR signaling in tumor microenvironment.
- Published in:
- Journal of Cellular Physiology, 2008, v. 214, n. 3, p. 559, doi. 10.1002/jcp.21260
- By:
- Publication type:
- Article
The MEK/MAPK pathway is involved in the resistance of breast cancer cells to the EGFR tyrosine kinase inhibitor gefitinib.
- Published in:
- Journal of Cellular Physiology, 2006, v. 207, n. 2, p. 420, doi. 10.1002/jcp.20588
- By:
- Publication type:
- Article